Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Kirkland’s Inc.’s ( KIRK - Analyst Report ) third-quarter 2011 earnings of 6 cents a share came in ahead of the Zacks Consensus Estimate of 4 cents per share. However, earnings were short of the prior-year quarter’s figures of 11 cents.
Quarter in Detail
Kirkland’s net sales went up 4.7% year over year to $97.1 million from $92.7 million in the year-ago quarter. Consolidated comparable store sales slipped 3.6% compared with a 2.4% decrease in the prior-year quarter.
On a year-over-year basis, gross profit contracted 3.9% to $36.1 million. Kirkland posted an operating income of $0.2 million, as against an operating income of $3.8 million posted in the year-ago quarter.
Other Financial Update
Kirkland’s exited the quarter with cash and cash equivalents of $60.3 million and no debt.
The Company opened 13 stores and closed 6 stores during the third quarter of 2011, bringing the total number of stores to 301 as of quarter’s end.
In addition, Kirkland’s repurchased 837,803 shares of common stock for a total of $8.0 million, or an average price of $9.50 per share.
It has repurchased an additional 80,548 shares since quarter end for a total of 918,351 shares. The Company has $31.1 million remaining under its repurchase authorization.
Guidance
Kirkland's expects to open approximately 8 new stores in the fourth quarter of fiscal 2011, representing a square footage growth of 10%.
The Company expects net sales to be in the range of $142 million to $145 million in the fourth quarter of fiscal 2011, while for the fiscal year sales are expected to be in the range of $423 million to $426 million.
Currently, Kirkland’s has a Zacks #2 Rank, which translates into a short-term 'Buy' rating. On a long term basis, we provide a "Neutral" rating on the stock.
Read the full Analyst Report on KIRK